Arsenic Trioxide Inhibits Neuroblastoma Growth in Vivo and Promotes Apoptotic Cell Death in Vitro
- 14 October 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 277 (1) , 179-185
- https://doi.org/10.1006/bbrc.2000.3651
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiationPublished by Elsevier ,2003
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institutionBone Marrow Transplantation, 1999
- The biology and treatment of acute progranulocytic leukemiaCurrent Opinion in Oncology, 1999
- Impaired Granulocytic Differentiation In Vitro in Hematopoietic Cells Lacking Retinoic Acid Receptors α1 and γBlood, 1998
- p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS–KCNR human neuroblastoma cell lineOncogene, 1998
- Activation of Three Distinct RXR/RAR Heterodimers Induces Growth Arrest and Differentiation of Neuroblastoma CellsPublished by Elsevier ,1997
- Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.Journal of Clinical Oncology, 1996
- A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage.Proceedings of the National Academy of Sciences, 1993
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988